Framingham

Framingham is a healthcare technology company that utilizes artificial intelligence to redefine cardiovascular risk assessment and disease management. Drawing its name and inspiration from the landmark Framingham Heart Study, the company develops a platform that integrates diverse data streams—including electronic health records, imaging, and biomarkers—to provide clinicians with precise, actionable insights. Their AI models are designed to detect early signs of heart disease and predict future adverse events more accurately than traditional risk calculators. Framingham aims to transform preventative cardiology by enabling personalized treatment strategies that reduce the global burden of cardiovascular illness. The company is currently scaling its platform to support healthcare systems in identifying high-risk patients and optimizing clinical outcomes.